Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hochhauser

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
BMC Cancer|October 2, 2012
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samplesVictoria J Spanswick, Helen L Lowe, Claire Newton, et al.
Molecular Cancer Therapeutics|January 24, 2007
Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamideDaniel Hochhauser, Minal Kotecha, Caroline O'hare, et al.
Chembiochem : a European Journal of Chemical Biology|October 29, 2005
Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multidrug resistant (MDR1) geneKaren L Buchmueller, Zarmeen Taherbhai, Cameron M Howard, et al.
Oncotarget|April 15, 2015
Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatmentLaura R H Ip, George Poulogiannis, Felipe Cia Viciano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumorsDaniel Hochhauser, Timothy Meyer, Victoria J Spanswick, et al.
Molecular Cancer Therapeutics|May 17, 2008
Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78Minal Kotecha, Jerome Kluza, Geoff Wells, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2015
Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal CancerVessela Vassileva, Vineeth Rajkumar, Mario Mazzantini, et al.
Bioorganic & Medicinal Chemistry|November 6, 2007
Targeting the inverted CCAAT Box-2 of the topoisomerase IIalpha gene: DNA sequence selective recognition by a polyamide-intercalator as a staggered dimerHilary Mackay, Toni Brown, Jim S Sexton, et al.
Nanoscale|November 3, 2021
Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous <i>in vivo</i> delivery of tyrosine kinase inhibitors and kinase activity biosensorsRobin Bofinger, Gregory Weitsman, Rachel Evans, et al.
British Journal of Cancer|October 21, 2015
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinomaNadeera De Silva, Laura Schulz, Anna Paterson, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
BMC Cancer|October 2, 2012
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samplesVictoria J Spanswick, Helen L Lowe, Claire Newton, et al.
Molecular Cancer Therapeutics|January 24, 2007
Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamideDaniel Hochhauser, Minal Kotecha, Caroline O'hare, et al.
Chembiochem : a European Journal of Chemical Biology|October 29, 2005
Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multidrug resistant (MDR1) geneKaren L Buchmueller, Zarmeen Taherbhai, Cameron M Howard, et al.
Oncotarget|April 15, 2015
Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatmentLaura R H Ip, George Poulogiannis, Felipe Cia Viciano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumorsDaniel Hochhauser, Timothy Meyer, Victoria J Spanswick, et al.
Molecular Cancer Therapeutics|May 17, 2008
Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78Minal Kotecha, Jerome Kluza, Geoff Wells, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2015
Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal CancerVessela Vassileva, Vineeth Rajkumar, Mario Mazzantini, et al.
Bioorganic & Medicinal Chemistry|November 6, 2007
Targeting the inverted CCAAT Box-2 of the topoisomerase IIalpha gene: DNA sequence selective recognition by a polyamide-intercalator as a staggered dimerHilary Mackay, Toni Brown, Jim S Sexton, et al.
Nanoscale|November 3, 2021
Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous <i>in vivo</i> delivery of tyrosine kinase inhibitors and kinase activity biosensorsRobin Bofinger, Gregory Weitsman, Rachel Evans, et al.
British Journal of Cancer|October 21, 2015
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinomaNadeera De Silva, Laura Schulz, Anna Paterson, et al.
Pageof 7